Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L S Manning

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1991
Chemosensitivity and cytokine sensitivity of malignant mesotheliomaR V Bowman, L S Manning, M R Davis, et al.
The American Review of Respiratory Disease|June 1, 1989
Lysis of human malignant mesothelioma cells by natural killer (NK) and lymphokine-activated killer (LAK) cellsL S Manning, R V Bowman, S B Darby, et al.
Immunology and Cell Biology|August 1, 1995
Assessment of the therapeutic potential of cytokines, cytotoxic drugs and effector cell populations for the treatment of multiple myeloma using the 5T33 murine myeloma modelL S Manning, N L Chamberlain, M F Leahy, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|February 17, 1998
The efficacy of benzimidazole drugs against Plasmodium falciparum in vitroT S Skinner-Adams, T M Davis, L S Manning, et al.
Cancer|May 15, 1991
Interaction between dactinomycin and tumor necrosis factor in mesothelioma. Cachexia without oncolysisR V Bowman, D Whitaker, L S Manning, et al.
Immunology and Cell Biology|February 1, 1993
An analysis of the relationship between gamma delta T cell receptor V gene usage and non-major histocompatibility complex-restricted cytotoxicityN Mavaddat, B W Robinson, A H Rose, et al.
International Journal of Cancer|December 2, 1992
Establishment of a murine model of malignant mesotheliomaM R Davis, L S Manning, D Whitaker, et al.
Journal of Leukocyte Biology|August 1, 1985
Localization and characterization of macrophages in murine uterusJ S Hunt, L S Manning, D Mitchell, et al.
Cancer Treatment Reviews|May 1, 1995
Potential for cytokine therapy of malignant mesotheliomaD R Fitzpatrick, L S Manning, A W Musk, et al.
American Journal of Respiratory Cell and Molecular Biology|September 1, 1991
HLA antigen expression and malignant mesotheliomaT I Christmas, L S Manning, M R Davis, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cancer Chemotherapy and Pharmacology|January 1, 1991
Chemosensitivity and cytokine sensitivity of malignant mesotheliomaR V Bowman, L S Manning, M R Davis, et al.
The American Review of Respiratory Disease|June 1, 1989
Lysis of human malignant mesothelioma cells by natural killer (NK) and lymphokine-activated killer (LAK) cellsL S Manning, R V Bowman, S B Darby, et al.
Immunology and Cell Biology|August 1, 1995
Assessment of the therapeutic potential of cytokines, cytotoxic drugs and effector cell populations for the treatment of multiple myeloma using the 5T33 murine myeloma modelL S Manning, N L Chamberlain, M F Leahy, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|February 17, 1998
The efficacy of benzimidazole drugs against Plasmodium falciparum in vitroT S Skinner-Adams, T M Davis, L S Manning, et al.
Cancer|May 15, 1991
Interaction between dactinomycin and tumor necrosis factor in mesothelioma. Cachexia without oncolysisR V Bowman, D Whitaker, L S Manning, et al.
Immunology and Cell Biology|February 1, 1993
An analysis of the relationship between gamma delta T cell receptor V gene usage and non-major histocompatibility complex-restricted cytotoxicityN Mavaddat, B W Robinson, A H Rose, et al.
International Journal of Cancer|December 2, 1992
Establishment of a murine model of malignant mesotheliomaM R Davis, L S Manning, D Whitaker, et al.
Journal of Leukocyte Biology|August 1, 1985
Localization and characterization of macrophages in murine uterusJ S Hunt, L S Manning, D Mitchell, et al.
Cancer Treatment Reviews|May 1, 1995
Potential for cytokine therapy of malignant mesotheliomaD R Fitzpatrick, L S Manning, A W Musk, et al.
American Journal of Respiratory Cell and Molecular Biology|September 1, 1991
HLA antigen expression and malignant mesotheliomaT I Christmas, L S Manning, M R Davis, et al.
Pageof 3